FDA Inspection
Lonza Biologics Tuas Pte LtdLonza Biologics Tuas Pte Ltd – FDA Inspection, Sep 20, 2019
Record Details
This FDA Inspection record concerns Lonza Biologics Tuas Pte Ltd, with an inspection on September 20, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 7df57cf9-03c2-47be-9348-593423eacdaf
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1107165
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Lonza Biologics Tuas Pte Ltd
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 27, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 19, 2023 | Not classified | Office of Inspections and Investigations | |
| June 18, 2019 | Not classified | Office of Inspections and Investigations | |
| February 24, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 10, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Lonza Biologics Tuas Pte Ltd
- FDA Inspection 1277712 - 2023-06-27
- FDA Inspection 1255011 - 2023-05-19
- FDA Inspection 1108095 - 2019-06-18
- FDA Inspection 1016852 - 2017-02-24
- FDA Inspection 925069 - 2015-03-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.